These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18500823)

  • 1. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
    Cattaneo F; Nucifora G
    J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
    Spensberger D; Delwel R
    FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
    Wade PA; Gegonne A; Jones PL; Ballestar E; Aubry F; Wolffe AP
    Nat Genet; 1999 Sep; 23(1):62-6. PubMed ID: 10471500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
    McGilvray R; Walker M; Bartholomew C
    FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
    Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
    Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
    Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
    Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
    Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
    Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental roles of the Mi-2/NURD-associated protein p66 in Drosophila.
    Kon C; Cadigan KM; da Silva SL; Nusse R
    Genetics; 2005 Apr; 169(4):2087-100. PubMed ID: 15695365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes.
    Feng Q; Zhang Y
    Genes Dev; 2001 Apr; 15(7):827-32. PubMed ID: 11297506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deacetylation of p53 modulates its effect on cell growth and apoptosis.
    Luo J; Su F; Chen D; Shiloh A; Gu W
    Nature; 2000 Nov; 408(6810):377-81. PubMed ID: 11099047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.
    Fujita N; Jaye DL; Geigerman C; Akyildiz A; Mooney MR; Boss JM; Wade PA
    Cell; 2004 Oct; 119(1):75-86. PubMed ID: 15454082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.
    Criqui-Filipe P; Ducret C; Maira SM; Wasylyk B
    EMBO J; 1999 Jun; 18(12):3392-403. PubMed ID: 10369679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.
    Choi WI; Jeon BN; Yoon JH; Koh DI; Kim MH; Yu MY; Lee KM; Kim Y; Kim K; Hur SS; Lee CE; Kim KS; Hur MW
    Nucleic Acids Res; 2013 Jul; 41(13):6403-20. PubMed ID: 23658227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
    Jiang CL; Jin SG; Pfeifer GP
    J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
    Gozzini A; Rovida E; Dello Sbarba P; Galimberti S; Santini V
    Cancer Res; 2003 Dec; 63(24):8955-61. PubMed ID: 14695213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.